£34.76

Humana Combination Cancer Therapy: Modulators and Potentiators

Price data checked 3 days ago

View at Amazon

Price History & Forecast

Last 88 days • 88 data points

Historical
Generating forecast...
£35.61 £28.33 £29.92 £31.51 £33.09 £34.68 £36.27 28 January 2026 18 February 2026 12 March 2026 03 April 2026 25 April 2026

Price Distribution

Price distribution over 88 days • 7 price levels

Days at Price
Current Price
8 days 6 days 14 days 24 days 9 days 14 days · current 13 days 0 6 12 18 24 £29 £30 £33 £33 £34 £35 £36 Days at Price

Price Analysis

Most common price: £33 (24 days, 27.3%)

Price range: £29 - £36

Price levels: 7 different prices over 88 days

Description

Explore the evolving landscape of medical oncology with Combination Cancer Therapy: Modulators and Potentiators. This professional resource provides a deep look into how novel target agents and classic chemotherapies work together to improve patient outcomes. Expert physician-scientists and clinicians evaluate the most promising combinations for the future of cancer treatment. This text covers essential topics including optimal sequencing, pharmacokinetic interactions, and the impact on downstream cellular signals. You will find detailed information on targeted therapies directed at cell surface receptors like EGF-R and HER2, as well as the cell cycle (CDKs), signal transduction events (PKC and NF-kB), and apoptosis (bcl-2). Designed for medical professionals and researchers, the content offers focused insights into specific areas such as ovarian cancer, hematologic diseases, and breast cancer. Whether you are studying drug discovery or looking for data on therapeutic interactions, this volume serves as a detailed guide to the current state of cancer drug development.

Key Features

Expert clinical reviews of novel target agents and classic chemotherapies to identify promising future medical oncology treatments.

Detailed analysis of optimal drug sequencing and pharmacokinetic interactions for effective combination therapies.

In-depth coverage of cell surface receptor targets including EGF-R and HER2 to aid in drug discovery research.

Comprehensive study of signal transduction events and cellular processes such as PKC, NF-kB, and bcl-2 apoptosis.

Specialized sections focusing on specific disease areas including ovarian cancer, breast cancer, and hematologic diseases.

Technical insights into the cell cycle and CDKs to support advanced oncology research and development.

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
03 December 2004
Listed Since
28 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
99% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)
95% match

Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)

Humana

£84.34 23 Feb 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
95% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£147.91 10 Mar 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
95% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£117.40 15 Jan 2026
Cancer Drug Resistance (Cancer Drug Discovery and Development)
95% match

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Humana

£154.49 13 Jan 2026
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
95% match

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Humana

£149.75 13 Jan 2026
Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)
95% match

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)

Humana

£84.39 21 Feb 2026
Platinum-Based Drugs in Cancer Therapy (Cancer Drug Discovery and Development)
95% match

Platinum-Based Drugs in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£95.19 15 Feb 2026
Chemistry and Pharmacology of Anticancer Drugs
95% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£192.76 17 Apr 2026
CRC Press - Chemistry and Pharmacology of Anticancer Drugs
95% match

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£133.99 15 Apr 2026
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)
95% match

Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£144.18 08 Mar 2026
Wiley Molecular Cancer Therapeutics - Drug Discovery Book
95% match

Wiley Molecular Cancer Therapeutics - Drug Discovery Book

Wiley

£121.19 24 Apr 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
94% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£149.20 27 Jan 2026
Pharmaceutical Perspectives of Cancer Therapeutics
94% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£139.95 11 Jan 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
94% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£72.83 08 Mar 2026
Cancer Chemotherapy: Basic Science to the Clinic
94% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley-Blackwell

£47.19 16 Feb 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
94% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
94% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
94% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£148.78 19 Apr 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
94% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£104.18 27 Apr 2026
Cardiovascular Complications in Cancer Therapy (Current Clinical Pathology)
94% match

Cardiovascular Complications in Cancer Therapy (Current Clinical Pathology)

Humana

£73.91 25 Apr 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
94% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£18.99 22 Jan 2026
Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)
94% match

Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)

Humana

£219.73 09 Apr 2026
Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development)
94% match

Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£154.94 20 Jan 2026